Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis

Clinical trial NCT06718933 · RECRUITING

Trial details

NCT number: NCT06718933
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastatic Breast Cancer Brain Metastases

Start date: 2025-01-08
Primary completion: 2026-08-31
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.